Nineteen Sanofi staff transferred to Pennsylvania firm

Scientists will continue clinical research work in Laval

By Robert Frank

French pharmaceutical multinational Sanofi announced, Jan. 8, that it plans to “transition” 19 members of its clinical research team in Laval to an American firm.

“They will continue to work with us, and some will remain on the premises,” Sanofi spokeswoman Joanne Kennedy reassured The Suburban in an interview. “They will be working for a different employer, and their work will be managed by a third party.”

“Sanofi decided to look at how to work more efficiently in all our different business units and at how we run our clinical trials globally,” she explained. “That led to a decision to work with a preferred vendor,” Kennedy continued. “We wanted to ensure that our employees have the opportunity to work for this organization.”

Sanofi is known for its diabetes, cancer and cardiovascular treatments. She explained that the scientific staff affected “work in all variety of our different research trials and areas.”

The Suburban has learned that the third party firm is Research Pharmaceutical Services (RPS), a multinational corporation based in Fort Washington, Pennsylvania. RPS’ North American operations are headquartered in downtown Montreal.

Kennedy added that Sanofi is still on track next month to move into the new office tower. that it is constructing in Laval’s biotech city. The February move will also affect some 40 employees in St. Laurent who produce the company’s cosmeceutical product lines.

The company has, for the past 43 years, operated under various names in older facilities in Laval’s industrial park.

“For our pharmacy business, Sanofi employs about 450 people across Canada, 350 of whom are in Laval,” Kennedy concluded.

(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),

ga(‘create’, ‘UA-45892555-1’, ‘’);
ga(‘send’, ‘pageview’);

Wordpress Social Share Plugin powered by Ultimatelysocial